Natixis Care Dx, Inc. Transaction History

Natixis

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$28.19 - $46.6 $950,003 - $1.57 Million	-33,700 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$41.2 - $73.6 $7.54 Million - $13.5 Million	-183,100 Reduced 84.46%	33,700 $1.53 Million
Q3 2021 Nov 12, 2021	BUY	$59.15 - $91.99 $5.31 Million - $8.26 Million	89,800 Added 70.71%	216,800 $13.7 Million
Q2 2021 Aug 13, 2021	BUY	$63.02 - $95.11 $8 Million - $12.1 Million	127,000 New	127,000 $11.6 Million

218

51.1M

97.3K

43.3K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.15B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

Stay updated on Natixis with notifications on news.